Gilead to buy Immunomedics in $21B deal
Gilead to buy Immunomedics in $21B deal
Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the com…Read More
0 comments:
Post a Comment